Search research articles
Contact Us
Filters
Showing results (121-130 of 150) with videos related to
Page
of 15
Sort By:
Journal of the American Society of Hypertension : JASH
|
August 1, 2017
The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitus
Jens Jordan, Jens Tank, Karsten Heusser, et al.
Diabetes, Obesity & Metabolism
|
June 2, 2026
Insulin Sensitivity and Beta Cell Function With Macupatide Alone or With Dulaglutide in Type 2 Diabetes: A Phase 1b, Randomised Controlled Trial
Tim Heise, Eric Zijlstra, Andrea Mari, et al.
Diabetes, Obesity & Metabolism
|
February 23, 2026
Characterisation of steady-state pharmacokinetics and glucodynamics of once-weekly insulin efsitora alfa in individuals with type 2 diabetes
Jennifer Leohr, Oliver Klein, Tim Heise, et al.
Diabetes Care
|
November 17, 2020
Sustained Intensive Treatment and Long-term Effects on HbA<sub>1c</sub> Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI
Marcus Lind, Arndís F Ólafsdóttir, Irl B Hirsch, et al.
Diabetes, Obesity & Metabolism
|
December 18, 2020
ADO09, a co-formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes
Grit Andersen, Grégory Meiffren, Susanne Famulla, et al.
Diabetes Technology & Therapeutics
|
April 3, 2018
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)
Arndís F Ólafsdóttir, William Polonsky, Jan Bolinder, et al.
The Lancet. Diabetes & Endocrinology
|
April 25, 2022
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial
Tim Heise, Andrea Mari, J Hans DeVries, et al.
Diabetes, Obesity & Metabolism
|
December 20, 2018
BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study
Tim Heise, Grégory Meiffren, Bertrand Alluis, et al.
Diabetes, Obesity & Metabolism
|
November 27, 2016
Novel hepato-preferential basal insulin peglispro (BIL) does not differentially affect insulin sensitivity compared with insulin glargine in patients with type 1 and type 2 diabetes
Niels Porksen, Helle Linnebjerg, Parag Garhyan, et al.
Frontiers in Aging
|
July 13, 2022
A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage
Giulia Lizzo, Eugenia Migliavacca, Daniela Lamers, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 150) with videos related to
Sort By:
Page
of 15
Journal of the American Society of Hypertension : JASH
|
August 1, 2017
The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitus
Jens Jordan, Jens Tank, Karsten Heusser, et al.
Diabetes, Obesity & Metabolism
|
June 2, 2026
Insulin Sensitivity and Beta Cell Function With Macupatide Alone or With Dulaglutide in Type 2 Diabetes: A Phase 1b, Randomised Controlled Trial
Tim Heise, Eric Zijlstra, Andrea Mari, et al.
Diabetes, Obesity & Metabolism
|
February 23, 2026
Characterisation of steady-state pharmacokinetics and glucodynamics of once-weekly insulin efsitora alfa in individuals with type 2 diabetes
Jennifer Leohr, Oliver Klein, Tim Heise, et al.
Diabetes Care
|
November 17, 2020
Sustained Intensive Treatment and Long-term Effects on HbA<sub>1c</sub> Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI
Marcus Lind, Arndís F Ólafsdóttir, Irl B Hirsch, et al.
Diabetes, Obesity & Metabolism
|
December 18, 2020
ADO09, a co-formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes
Grit Andersen, Grégory Meiffren, Susanne Famulla, et al.
Diabetes Technology & Therapeutics
|
April 3, 2018
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)
Arndís F Ólafsdóttir, William Polonsky, Jan Bolinder, et al.
The Lancet. Diabetes & Endocrinology
|
April 25, 2022
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial
Tim Heise, Andrea Mari, J Hans DeVries, et al.
Diabetes, Obesity & Metabolism
|
December 20, 2018
BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study
Tim Heise, Grégory Meiffren, Bertrand Alluis, et al.
Diabetes, Obesity & Metabolism
|
November 27, 2016
Novel hepato-preferential basal insulin peglispro (BIL) does not differentially affect insulin sensitivity compared with insulin glargine in patients with type 1 and type 2 diabetes
Niels Porksen, Helle Linnebjerg, Parag Garhyan, et al.
Frontiers in Aging
|
July 13, 2022
A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage
Giulia Lizzo, Eugenia Migliavacca, Daniela Lamers, et al.
Page
of 15